Cardiovascular Disease Risk Factors Predict the Development of Type 2 Diabetes

Cardiovascular Disease Risk Factors Predict the Development of Type 2 Diabetes The Insulin Resistance Atherosclerosis Study Ralph B. D’Agostino, Jr , PHD 1 , Richard F. Hamman , MD, DRPH 2 , Andrew J. Karter , PHD 3 , Leena Mykkanen , MD 4 , Lynne E. Wagenknecht , DRPH 1 , Steven M. Haffner , MD, MP...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2004-09, Vol.27 (9), p.2234-2240
Hauptverfasser: Ralph B. D’Agostino, Jr, Richard F. Hamman, Andrew J. Karter, Leena Mykkanen, Lynne E. Wagenknecht, Steven M. Haffner
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cardiovascular Disease Risk Factors Predict the Development of Type 2 Diabetes The Insulin Resistance Atherosclerosis Study Ralph B. D’Agostino, Jr , PHD 1 , Richard F. Hamman , MD, DRPH 2 , Andrew J. Karter , PHD 3 , Leena Mykkanen , MD 4 , Lynne E. Wagenknecht , DRPH 1 , Steven M. Haffner , MD, MPH 5 and for the Insulin Resistance Atherosclerosis Study Investigators 1 Department of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina 2 Department of Preventive Medicine and Biometrics, University of Colorado, Health Science Center, Denver, Colorado 3 Division of Research, Kaiser Permanente, Oakland, California 4 Department of Medicine, University of Kuopio, Kuopio, Finland 5 Department of Medicine, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas Address correspondence and reprint requests to Ralph D’Agostino, Jr., PhD, Department of Public Health Science, Biostatistics Section, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157. E-mail: rdagosti{at}wfubmc.edu Abstract OBJECTIVE —In a few previous studies, cardiovascular disease (CVD) risk factors (RFs) have been shown to predict diabetes. Our objective was to determine whether the presence of CVD RFs predict the eventual development of diabetes after controlling for known RFs, such as directly measured insulin resistance and obesity. RESEARCH DESIGN AND METHODS —We studied 872 participants with normal or impaired glucose tolerance (IGT) who were enrolled at baseline in the Insulin Resistance Atherosclerosis Study (IRAS). Of these, 143 (16%) developed type 2 diabetes in 5 years. Using these participants, a series of logistic regression models were fit to address the question. RESULTS —Significant RFs for developing type 2 diabetes included high plasminogen activator inhibitor-1, hypertension, high triglycerides, low levels of HDL cholesterol, and IGT. The 5-year cumulative incidence of type 2 diabetes by the number of RFs (0–5) was as follows: no RFs, 11 of 230 = 5%; one RF, 31 of 278 = 11%; two RFs, 36 of 202 = 18%; three RFs, 41 of 110 = 37%; four RFs, 19 of 42 = 45%; and five RFs, 5 of 10 = 50% ( P < 0.001). The odds ratio (OR) for conversion to type 2 diabetes for each additional RF was 2.1 (95% CI 1.78–2.46) after adjusting for age, sex, ethnicity, and center. After further adjustment for insulin resistance, determined by the frequently sampled intravenous glucose tolerance test and waist circumfer
ISSN:0149-5992
1935-5548
DOI:10.2337/diacare.27.9.2234